Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
By L. Mandell, R. Wunderink, A. Anzueto, J. Bartlett, G. Campbell, Nathan C. Dean, S. Dowell, D. Musher, Michael S. Niederman, A. Torres and 2 more. 2007
6,366 citations recorded by the source corpus.
Lionel A. Mandell, Richard G. Wunderink, Antonio Anzueto, John G. Bartlett, G. Douglas Campbell, Nathan C. Dean, Scott F. Dowell, Thomas M. File, Jr. Daniel M. Musher, Michael S. Niederman, Antonio Torres, and Cynthia G. Whitney McMaster University Medical School, Hamilton, Ontario, Canada; Northwestern University Feinberg School of Medicine, Chicago, Illinois; University of Texas Health Science Center and South Texas Veterans Health Care System, San Antonio, and Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas; Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Mississippi School of Medicine, Jackson; Division of Pulmonary and Critical Care Medicine, LDS Hospital, and University of Utah, Salt Lake City, Utah; Centers for Disease Control and Prevention, Atlanta, Georgia; Northeastern Ohio Universities College of Medicine, Rootstown, and Summa Health System, Akron, Ohio; State University of New York at Stony Brook, Stony Brook, and Department of Medicine, Winthrop University Hospital, Mineola, New York; and Cap de Servei de Pneumologia i Allergia Respiratoria, Institut Clinic del Torax, Hospital Clinic de Barcelona, Facultat de Medicina, Universitat de Barcelona, Institut d’Investigacions Biomediques August Pi i Sunyer, CIBER CB06/06/0028, Barcelona, Spain.
Subfields: Emergency Medicine, Epidemiology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Greg S. Corrado
- Michael D. Howell
- Atul J. Butte
- D. Alland
- Michaela Hardt
- A. Croxatto
- F. Tenover
- Alvin Rajkomar
Citations in the corpus
- Variable generalization performance of a deep learning model to detect pneumonia in chest radiographs: A cross-sectional study (2018, background): “Positive findings on chest radiograph are necessary but not sufficient for the diagnosis of pneumonia, which is only made when the patient also exhibits a “constellation of suggestive clinical features” [26].”
- Scalable and accurate deep learning with electronic health records (2018, methodology): “ of only 27 variables, rely on traditional generalized linear models, and are built using data at a single center. In clinical practice, simpler models are most commonly deployed, such as the CURB-65 [68, 60], which is a 5-factor model, or single-parameter warning scores [20, 45]. A major challenge ”
- “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study” (2020, positive): “It establishes the level of dependence of a patient according to his or her needs and clinical criteria: CURB-65 and SOFA scale and ATS/IDSA criteria [27].”
- Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children (2020, background): “guidelines for the management of communityacquired pneumonia in adults suggest a 25% rate of high-level macrolide resistance in the community as the threshold beyond which macrolides should not be used (110, 111).”
- Mycoplasma pneumoniae from the Respiratory Tract and Beyond (2017, background): “A final reason for the lack of widespread diagnostic testing is that many clinicians have not expressed an urgent need to have microbiological confirmation for patient management purposes, and this opinion is reflected in clinical practice guidelines for treatment of community-acquired pneumonias th”
- Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications (2010, background): “In humans, the cytokine profile for 23 subjects with CAP treated with clarithromycin at 500 mg twice daily for 7 days was compared with that for subjects treated with amoxicillin at 1 g three times daily for 7 days.”
- SARS2-CoV-2 and Stroke in a New York Healthcare System (2020, background): “SC IE NC ES ejection fraction; and (5) atrial fibrillation with or without a rapid ventricular response.”
- Weakly Supervised Deep Learning for COVID-19 Infection Detection and Classification From CT Images (2020, neutral): “of America/American Thoracic Society [18].”
- Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. (2008, background): “, Legionella pneumophila, Pneumocystis jiroveci, or Mycobacterium tuberculosis, for which a prolonged duration of antibiotic therapy is standard-of-care (17); (2) severe infections due to viruses or parasites (e.”
- The Importance of Respiratory Rate Monitoring: From Healthcare to Sport and Exercise (2020, methodology): “Given the fact that f R is altered substantially by pneumonia, f R is among the variables used to define criteria for the diagnosis of severe pneumonia (≥30 breaths/min) and for the achievement of clinical stability (≤24 breaths/min) [94,95].”
- Better Tests, Better Care: Improved Diagnostics for Infectious Diseases (2013, methodology): “Microbiologic testing for an etiologic diagnosis in CAP is presented as “controversial” in the 2007 IDSA/American Thoracic Society (ATS) guidelines, because at the time, the literature indicated a low diagnostic yield with traditional culture and sensitivity and hence minimal impact on clinical care”
- Macrolides and community-acquired pneumonia: is quorum sensing the key? (2010, background): “Th e Infectious Diseases Society of America/American Th oracic Society guidelines suggest therapy with a β-lactam antibiotic, with the addition of either a macrolide or fl uoroquinolone antibiotic [4], whilst the British Th oracic Society recommends initiating a β-lactam/macrolide antibiotic combina”
- How to manage Pseudomonas aeruginosa infections (2018, background): “aeruginosa is completely different from the standard therapy to treat common pathogens in CAP, current guidelines stratify therapy recommendations on the basis of pseudomonal risk factors [91].”